Brasschaat, Belgium

Rolf Hoffmann

This inventor holds 1 USPTO granted patent. Top assignee: Degussa-Huuls. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rolf Hoffmann. Retrieved from https://idiyas.com/inventor/rolf-hoffmann-8tk959lz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rolf Hoffmann: Innovator in Cyclic 4-Oxoamidines

Introduction

Rolf Hoffmann is a notable inventor based in Brasschaat, Belgium. He has made significant contributions to the field of chemistry, particularly in the preparation of cyclic 4-oxoamidines. His work has implications for the development of active substances with biological action.

Latest Patents

Hoffmann holds a patent for a process titled "Process for the preparation of cyclic 4-oxoamidines." This invention outlines a method for obtaining cyclic 4-oxoamidines through the reaction of condensation products of aldehydes and aminonitriles or amino acid amides with oxidizing agents. The process yields these compounds in good to very good yields, showcasing its effectiveness.

Career Highlights

Rolf Hoffmann is associated with Degussa-Hüls, a company known for its innovative chemical solutions. His work at the company has allowed him to explore and develop new methodologies in chemical synthesis.

Collaborations

Throughout his career, Hoffmann has collaborated with esteemed colleagues such as Karlheinz Drauz and Ivan Pilgrims. These partnerships have contributed to the advancement of his research and the successful development of his patented processes.

Conclusion

Rolf Hoffmann's contributions to the field of chemistry, particularly through his patent on cyclic 4-oxoamidines, highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence the development of biologically active substances.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…